279 related articles for article (PubMed ID: 27796149)
1. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study.
Padrik P; Valter A; Valter E; Baburin A; Innos K
Acta Oncol; 2017 Jan; 56(1):52-58. PubMed ID: 27796149
[TBL] [Abstract][Full Text] [Related]
2. Time trends in population-based breast cancer survival in Estonia: analysis by age and stage.
Baburin A; Aareleid T; Padrik P; Valvere V; Innos K
Acta Oncol; 2014 Feb; 53(2):226-34. PubMed ID: 23767956
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
Bay C; Kejs AM; Storm HH; Engholm G
Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
[TBL] [Abstract][Full Text] [Related]
5. Increasing kidney cancer incidence and survival in Estonia: role of age and stage.
Innos K; Sepp T; Baburin A; Kotsar A; Lang K; Padrik P; Aareleid T
Acta Oncol; 2019 Jan; 58(1):21-28. PubMed ID: 30280624
[TBL] [Abstract][Full Text] [Related]
6. Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.
Ojamaa K; Veerus P; Baburin A; Everaus H; Innos K
Int J Gynecol Cancer; 2017 Jan; 27(1):44-49. PubMed ID: 27870707
[TBL] [Abstract][Full Text] [Related]
7. Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening.
Innos K; Reima H; Baburin A; Paapsi K; Aareleid T; Soplepmann J
Cancer Epidemiol; 2018 Feb; 52():112-119. PubMed ID: 29294434
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014.
Innos K; Baburin A; Kotsar A; Eiche IE; Lang K
Scand J Urol; 2017 Dec; 51(6):442-449. PubMed ID: 29092653
[TBL] [Abstract][Full Text] [Related]
9. Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.
Ojamaa K; Innos K; Baburin A; Everaus H; Veerus P
BMC Cancer; 2018 Nov; 18(1):1075. PubMed ID: 30404606
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in cancer survival in Estonia: a population-based study.
Innos K; Padrik P; Valvere V; Aareleid T
BMC Cancer; 2015 Feb; 15():72. PubMed ID: 25886269
[TBL] [Abstract][Full Text] [Related]
11. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
12. Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study.
Aareleid T; Zimmermann ML; Baburin A; Innos K
BMC Cancer; 2017 Aug; 17(1):596. PubMed ID: 28854969
[TBL] [Abstract][Full Text] [Related]
13. Childhood cancer incidence and survival trends in Estonia (1970-2016): a nationwide population-based study.
Paapsi K; Baburin A; Mikkel S; Mägi M; Saks K; Innos K
BMC Cancer; 2020 Jan; 20(1):30. PubMed ID: 31924184
[TBL] [Abstract][Full Text] [Related]
14. Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.
Schoffer O; Schülein S; Arand G; Arnholdt H; Baaske D; Bargou RC; Becker N; Beckmann MW; Bodack Y; Böhme B; Bozkurt T; Breitsprecher R; Buchali A; Burger E; Burger U; Dommisch K; Elsner G; Fernschild K; Flintzer U; Funke U; Gerken M; Göbel H; Grobe N; Gumpp V; Heinzerling L; Kempfer LR; Kiani A; Klinkhammer-Schalke M; Klöcking S; Kreibich U; Knabner K; Kuhn P; Lutze S; Mäder U; Maisel T; Maschke J; Middeke M; Neubauer A; Niedostatek A; Opazo-Saez A; Peters C; Schell B; Schenkirsch G; Schmalenberg H; Schmidt P; Schneider C; Schubotz B; Seide A; Strecker P; Taubenheim S; Wackes M; Weiß S; Welke C; Werner C; Wittekind C; Wulff J; Zettl H; Klug SJ
BMC Cancer; 2016 Dec; 16(1):936. PubMed ID: 27919243
[TBL] [Abstract][Full Text] [Related]
15. Cancer patient survival in Estonia 1995-2009: time trends and data quality.
Innos K; Baburin A; Aareleid T
Cancer Epidemiol; 2014 Jun; 38(3):253-8. PubMed ID: 24726824
[TBL] [Abstract][Full Text] [Related]
16. Survival for colon and rectal cancer in Estonia: role of staging and treatment.
Innos K; Soplepmann J; Suuroja T; Melnik P; Aareleid T
Acta Oncol; 2012 Apr; 51(4):521-7. PubMed ID: 22098601
[TBL] [Abstract][Full Text] [Related]
17. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
Dal H; Boldemann C; Lindelöf B
Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage.
Vranova J; Arenbergerova M; Arenberger P; Vrana A; Zivcak J; Kolarova H; Rosina J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):438-46. PubMed ID: 23128825
[TBL] [Abstract][Full Text] [Related]
19. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
20. Incidence trends and survival of skin melanoma and squamous cell carcinoma in Cluj County, Romania.
Şuteu O; Blaga ML; Nicula F; Şuteu P; Coza O; Achimaş-Cadariu P; Coza D
Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S176-S182. PubMed ID: 28914690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
